Nutex Health, Inc. logo

Nutex Health, Inc.

NUTX

NASDAQHealthcareMedical - Care Facilities

Latest quote

$185.71

−$2.70 · -1.43%

Aug 21, 3:55 PM ET

NUTX company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

87

Deep Value

Momentum

70

Gaining

Sentiment

77

Bullish

Risk resilience

46

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Thomas T. Vo
Listed since
Apr 4, 2022
Employees
1,037

Market position

Volume
114.86K
0.76× average
Average volume
151.35K
Average daily volume
Market cap
1.28B USD
Beta
1.99
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
7.09×
P/B (TTM)
3.16×
P/S (TTM)
1.51×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
51.26%
Operating margin
43.02%
Net margin
21.25%

Financial health

Debt / equity
0.88×
Altman Z-score
4.13
Piotroski F-score
6 of 9

Earnings

Latest fiscal-year EPS
10.48
FY2025 · +7.93% year over year
Latest fiscal-year revenue
875.26M USD
FY2025 · +82.36% year over year
Next fiscal-year EPS consensus
28.3
FY2026 · 3 analysts
Next fiscal-year revenue consensus
869.68M USD
FY2026 · 3 analysts

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend46.94-6.62-60.19-113.75FY21FY22FY23FY24FY25FY26FY27

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend1.06B751.72M447.48M143.23MFY21FY22FY23FY24FY25FY26FY27

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$310

66.81% upside
Past 12 months12-month forecastHigh $310Average $310Low $310

Recent analyst actions

3 institutions
Lake StreetmaintainBuy

NUTX news

Corporate actions

Corporate action history

Stock split

Effective Jul 3, 2024

1:10

Stock split

Effective Apr 10, 2024

1:15

Stock split

Effective Nov 1, 2019

1:500

NUTX peers

ETFs holding NUTX

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research NUTX

research.disclaimer